This article describes a new way of identifying possible non-stimulant ADHD therapeutics, which can have fewer side effects than their stimulant counterparts. The most common first-line therapeutic treatment for attention-deficit/hyperactivity disorder (ADHD) is methylphenidate. However, this medication has a number of serious side effects, including weight loss, insomnia, and hypertension. The development of non-stimulant-based therapeutics...